Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.60
Bid: 42.48
Ask: 42.56
Change: -0.08 (-0.19%)
Spread: 0.08 (0.188%)
Open: 42.86
High: 42.86
Low: 42.10
Prev. Close: 42.68
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

8 Feb 2024 14:00

RNS Number : 4858C
Assura PLC
08 February 2024

8 February 2024

Assura plc

Capital markets event

Assura plc ("Assura"), the leading primary care property investor and developer, is today hosting a capital markets presentation and site tour for analysts and institutional investors.

Assura has identified several areas of emerging opportunities (NHS Trusts, private providers, mental health and Ireland) that are now becoming meaningful contributors to our portfolio, rental income and cash flow.

Members of the senior management team will present an update on our strategic approach to these emerging opportunities, outlining why we are targeting these areas alongside our existing GP medical centres and how our skills and capabilities mean we are well placed to become a market leader.

Specifically focused on the private market, the presentation will detail:

· The state of the UK healthcare market and resultant increasing demand for high-quality, sustainable healthcare buildings in a community setting

· Overview of trends and market opportunity in the private market segment

· Assura's capabilities in capturing this opportunity; to complement its existing GP centre portfolio

· An overview of recent private market development completions

· Recent investments and asset enhancements within the mental health segment will also be highlighted

There will be a subsequent site tour to showcase Assura's recently completed, state-of-the-art cancer care facility in Guildford.

Jonathan Murphy, CEO of Assura, said: "There is significant demand for high-quality, sustainable healthcare buildings in a community setting to alleviate the considerable and growing pressures facing the NHS whilst improving the significantly underinvested existing estate. Each of these emerging areas is closely aligned with Assura's existing portfolio to relieve pressure on the health system; has attractive investment characteristics with a strong underlying tenant covenant and offers opportunities for future growth, which Assura is well placed to capture."

No new material trading information will be disclosed. A copy of the presentation is available on the Assura plc website at: https://www.assuraplc.com/investor-relations/reports-and-presentations

- ENDS -

Assura plc David Purcell, Investor Relations Director

Tel: 0161 515 2043 Email: Investor@assura.co.uk

FGS Global

Gordon SimpsonGrace Whelan

Tel: 0207 251 3801 Email: Assura@fgsglobal.com

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
UPDUWAWRSBUURRR
Date   Source Headline
7th Dec 202110:55 amRNSDirector/PDMR Shareholding
2nd Dec 20218:57 amRNSNotice of Dividend
30th Nov 20217:00 amRNSTotal Voting Rights
29th Nov 20217:00 amRNSCapital Markets Webinar
18th Nov 20219:42 amRNSHolding(s) in Company
16th Nov 20215:22 pmRNSHolding(s) in Company
15th Nov 20219:52 amRNSDirector/PDMR Shareholding
11th Nov 20214:32 pmRNSResult of Placing
11th Nov 20217:01 amRNSPrimaryBid offer
11th Nov 20217:00 amRNSProposed equity placing of new ordinary shares
11th Nov 20217:00 amRNSInterim Results 2021
9th Nov 202112:07 pmRNSDirector/PDMR Shareholding
8th Nov 20214:04 pmRNSHolding(s) in Company
5th Nov 20217:00 amRNSInvestor Presentation
29th Oct 20217:00 amRNSNotice of Interim Results
29th Oct 20217:00 amRNSTotal Voting Rights
27th Oct 20213:51 pmRNSHolding(s) in Company
25th Oct 20217:58 amRNSIssue of Consideration Shares
19th Oct 20214:15 pmRNSDirector/PDMR Shareholding
13th Oct 20212:31 pmRNSAppointment of Joint Corporate Broker
11th Oct 20217:00 amRNSScrip Dividend Declaration
7th Oct 20219:14 amRNSDirector/PDMR Shareholding
5th Oct 20217:00 amRNSTrading Update
4th Oct 20212:58 pmRNSHolding(s) in Company
21st Sep 20217:00 amRNSHolding(s) in Company
20th Sep 20214:44 pmRNSHolding(s) in Company
17th Sep 20219:33 amRNSScrip Calculation Price
16th Sep 20214:27 pmRNSHolding(s) in Company
14th Sep 20214:15 pmRNSHolding(s) in Company
13th Sep 20219:08 amRNSHolding(s) in Company
7th Sep 20219:02 amRNSDirector/PDMR Shareholding
2nd Sep 20217:00 amRNSNotice of Dividend
6th Aug 20219:24 amRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSReduction of RCF
28th Jul 20214:23 pmRNSHolding(s) in Company
26th Jul 20215:30 pmRNSHolding(s) in Company
26th Jul 20218:57 amRNSHolding(s) in Company
20th Jul 20211:56 pmRNSDirector/PDMR Shareholding
15th Jul 20219:56 amRNSExercise of Nil Cost Options under PSP
12th Jul 20211:00 pmRNSScrip Dividend Declaration
8th Jul 202112:20 pmRNSDirector/PDMR Shareholding
8th Jul 202110:08 amRNSDirector/PDMR Shareholding
6th Jul 20212:15 pmRNSResult of AGM
6th Jul 202111:39 amRNSAdditional Listing
6th Jul 20217:00 amRNSTrading Update
28th Jun 20211:02 pmRNSHolding(s) in Company
23rd Jun 20214:01 pmRNSPricing of £300m Sustainability Bond
22nd Jun 20215:05 pmRNSHolding(s) in Company
17th Jun 20219:52 amRNSScrip Calculation Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.